Antipsychotic dose and weight gain: Long‐term evidence from a retrospective study using electronic health records

Aug-19

Mental Health Nephrology Pharmacoepidemiology

AUTHORS : Juan Carlos Bazo-Alvarez, Research Department of Primary Care and Population Health, University College London, Rowland Hill Street, London, NW3 2PF, UK – Email: juan.alvarez.16@ucl.ac.uk – Profile: https://www.ucl.ac.uk/epidemiology-health-care/juan-carlos-bazo-alvarez AND https://iris.ucl.ac.uk/iris/browse/profile?upi=JBAZO59

JOURNAL : Pharmacoepidemiology and Drug Safety

REFERENCE: 28(S2):567

DOI : 10.1002/pds.4864

Antipsychotic dose and weight gain: Long‐term evidence from a retrospective study using electronic health records

More publications

Comparative effect of aspirin versus clopidogrel monotherapy on incident type 2 diabetes in patients with atherosclerotic cardiovascular diseases: A target trial emulation study

Postoperative Weight Loss After Antiobesity Medications and Revision Risk After Joint Replacement

Comparative effectiveness and prescribing trends of modified release versus immediate release indapamide in patients with hypertension: cohort study